CERT.US Certara Inc

Healthcare Health Care Technology USA Stocks
11.57 USD
Close of Nov 14, 2026
4.45 12.61
Market cap
USD 1.76B
P/E
-
P/B
1.86x
ROE
-8.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CERT.US undervalued?

Graham number

The Graham number of Certara Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Certara Inc fundamental analysis

No fundamental analysis for Certara Inc yet.

Certara Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Certara Inc

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physio…

Full company profile